FdaApplication
NDA 020103
Identifiers
- fda_app_no: NDA020103
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | NDA |
| approval_date | 1992-12-31 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZOFRAN | ONDANSETRON HYDROCHLORIDE | EQ 24MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ZOFRAN | ONDANSETRON HYDROCHLORIDE | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ZOFRAN | ONDANSETRON HYDROCHLORIDE | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
3 products